HCA Healthcare (HCA) TD Cowen 46th Annual Health Care Conference summary
Event summary combining transcript, slides, and related documents.
TD Cowen 46th Annual Health Care Conference summary
3 Mar, 2026Strategic initiatives and resiliency planning
Four focus areas drive the resiliency program: revenue integrity, asset optimization, fixed cost, and variable cost, targeting a $400 million benefit by 2026 to offset ACA-related headwinds.
Hundreds of work streams are underway, with only those far enough along included in the 2026 guidance.
The program is positioned as a multi-year, enterprise-wide effort, continuing through the decade.
Financial modeling and headwinds
ACA APTC expiration is modeled as a $600–$900 million headwind for 2026, with key assumptions around attrition rates, metal tier shifts, and coverage transitions.
15–20% of those leaving exchanges are expected to move to employer-sponsored insurance, with the rest becoming uninsured.
Updates on these assumptions will be provided in quarterly calls as data matures.
Operational trends and capacity management
Outpatient revenue growth outpaced inpatient in Q4, with declines in lower acuity surgeries and Medicaid volumes offset by growth in other payer mixes.
Inpatient occupancy averages 73%, managed through adding 600–700 beds annually and reducing length of stay.
No immediate capacity constraints are expected, with planning focused on maintaining occupancy in the 70–75% range.
Latest events from HCA Healthcare
- Q3 revenue and net income rose sharply, but hurricane impacts will weigh on full-year results.HCA
Q3 20248 Jul 2026 - Strategic execution, AI, and disciplined investment drive growth amid regulatory and exchange headwinds.HCA
2026 KeyBanc Capital Markets Healthcare Forum8 Jul 2026 - 2024 delivered robust growth and resilience, with 2025 guidance signaling continued strength.HCA
Q4 20248 Jul 2026 - Q1 2026 revenue rose 4.3% to $19.1B, net income $1.62B, and guidance was reaffirmed.HCA
Q1 20268 Jul 2026 - Q1 2025 saw 5.7% revenue growth, higher EPS, strong capital returns, and reaffirmed guidance.HCA
Q1 20258 Jul 2026 - AI, network expansion, and tech upgrades drive efficiency amid regulatory and margin pressures.HCA
47th Annual Raymond James Institutional Investor Conference8 Jul 2026 - Record 2025 growth and strong 2026 outlook, with stable margins and major investments planned.HCA
Q4 20258 Jul 2026 - Strong volume growth, stable costs, and robust capital deployment drive positive outlook.HCA
UBS Global Healthcare Conference8 Jul 2026 - EBITDA headwinds from APTC expiration are manageable; growth and innovation initiatives remain on track.HCA
RBC Capital Markets Global Healthcare Conference 202620 May 2026 - Director elections, auditor ratification, and key shareholder proposals dominated the meeting.HCA
AGM 20266 May 2026